Critical Success Factors in Patient Safety Strategies
Gabriele Dallmann | 06/14/2011
In this Pharma IQ interview Nabil Al-Tawil, Principal Investigator of the Phase I Unit at Karolinska University Hospital, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation in phase 1 clinical development. Al-Tawil explains the importance of benchmarking the latest strategies to prevent late stage failure and allowing information-rich decisions to be made during early clinical development. He also discusses critical success factors in patient safety strategies, th...
To continue reading this story Click Here